
|Articles|September 1, 2003
Mixed Reviews
Author(s)Suzette Hill
Hermosa Beach, Calif. - Though not yet FDA-approved for use in the United States, Reviderm Intra is a hyaluronic gel filler with a shelf life that already may have passed, according to Gail Humble, M.D., medical director of Blue Pacific Aesthetic Medical Group in Hermosa Beach, Calif.
Advertisement
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
Phase 3 Data Position Zasocitinib as a Potential New Oral Option for Psoriasis
2
Highlighting Major Breakthroughs for Atopic Dermatitis and Psoriasis in 2025
3
First-in-Class Topical GT20029 Demonstrates Promising Phase 2 Efficacy and Tolerability for AGA
4
Topicals Demonstrate Targeted Control Across 3 Distinct Atopic Dermatitis Cases
5

















